769122-52-3

Upstream product

• 123355-73-7 (8aS,8bS)-4,6,7,8,8a,8b-hexahydro-3,6,6,8b-tetramethyl-2H-naphtho[1,8-bc]furan-2-one 
• 346688-10-6 (4aR,8S,8aS)-3,4,4a,5,6,7,8,8a-octahydro-4a,8-dihydroxy-1-hydroxymethyl-2,5,5,8a-tetramethylnaphthalene 
• 174956-51-5 (1S)-3'-ethenyl-2',4',4'-trimethyl-2'-cyclohexen-1-yl-2-butynoate 
• 97760-29-7 (S)-(-)-2,4,4-trimethyl-3-vinyl-2-cyclohexen-1-ol 
• 85679-49-8 2,4,4-trimethyl-3-vinyl-cyclohex-2-enone 
• 346688-16-2 (4aR,6aR,12bS)-3,4,4a,5,6,6a,12b-heptahydro-4a-hydroxy-4,4,6a,12b-tetramethyl-9-(3',4'-dimethoxyphenyl)-2H,11H-naphtho[2,1-b]pyrano[3,4-e]pyran-1,11(3H)-dione 
• 346688-14-0 (1S,4aR,6aR,12bS)-1,3,4,4a,5,6,6a,12b-octahydro-1,4a-dihydroxy-4,4,6a,12b-tetramethyl-9-(3',4'-dimethoxyphenyl)-2H,11H-naphtho[2,1-b]pyrano[3,4-e]pyran-11-one 
• 769122-48-7 (1R,4aR,6aR,12bS)-1,3,4,4a,5,6,6a,12b-octahydro-1,4a-dihydroxy-4,4,6a,12b-tetramethyl-9-(3',4'-dimethoxyphenyl)-2H,11H-naphtho[2,1-b]pyrano[3,4-e]pyran-11-one 
• 769122-46-5 (1S)-3'-ethenyl-2',4',4'-trimethyl-2'-cyclohexenyl 3,5-dinitrobenzoate 
• 346688-12-8 (4aR,8S,8aS)-1-formyl-3,4,4a,5,6,7,8,8a-octahydro-4a,8-dihydroxy-2,5,5,8a-tetramethylnaphthalene 
• 347393-59-3 (1aS,5aS,8aR,8bR)-1a,2,5a,7,8,8b-hexahydro-3,8,8,8b-tetramethyl-4H,6H-oxireno[4a,5]naphtho[1,8-bc]furan-4-one 
• 769122-49-8 (1R,4aR,6aR,12R,12aR,12bS)-1-acetoxy-1,3,4,4a,5,6,6a,12,12a,12b-decahydro-4a,12,12a-trihydroxy-4,4,6a,12b-tetramethyl-9-(3',4'-dimethoxyphenyl)-2H,11H-naphtho[2,1-b]pyrano[3,4-e]pyran-11-one 

Downstream Products

• 769126-98-9 (4aR,6aR,12aR,12bS)-3,4,4a,5,6,6a,12,12a,12b-nonahydro-4a,12a-dihydroxy-4,4,6a,12b-tetramethyl-9-(3',4'-dimethoxyphenyl)-2H,11H-naphtho[2,1-b]pyrano[3,4-e]pyran-1,11(3H)-dione 

Relevant academic research and scientific papers

Absolute stereochemistries and total synthesis of (+)-arisugacins a and B, potent, orally bioactive and selective inhibitors of acetylcholinesterase

In the current studies, we used the Kakisawa-Kashman modification of the Mosher NMR method to determine the complete absolute stereochemistry of arisugacins. We also report the convergent total synthesis of (+)-arisugacins A and B by a sequence including